Detalles de la búsqueda
1.
Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B.
J Hepatol
; 80(1): 41-52, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858684
2.
Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function.
Virol J
; 21(1): 77, 2024 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555445
3.
Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha.
BMC Endocr Disord
; 23(1): 115, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217910
4.
Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance.
Front Immunol
; 13: 1028921, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36211341
5.
Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis.
Front Immunol
; 12: 779347, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804072
6.
Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.
Dis Markers
; 2019: 3862024, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636735
7.
Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.
Medicine (Baltimore)
; 96(34): e7885, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28834904
8.
Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia.
Diabetes
; 66(8): 2137-2143, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28446519
Resultados
1 -
8
de 8
1
Próxima >
>>